DS
ANIP icon

David Shaw’s ANI Pharmaceuticals ANIP Stock Holding History

David Shaw’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,700
Closed -$228K – 3901
2019
Q4 		$228K Hold
3,700
– – ﹤0.01% 3749
2019
Q3 		$270K Buy
+3,700
New +$277K ﹤0.01% 3509
2017
Q1 		– Sell
-40,000
Closed -$2.42M – 3270
2016
Q4 		$2.42M Hold
40,000
– – ﹤0.01% 1850
2016
Q3 		$2.65M Buy
40,000
+10,000
+33% +$625K ﹤0.01% 1710
2016
Q2 		$1.68M Buy
+30,000
New +$1.46M ﹤0.01% 2056
2015
Q2 		– Sell
-20,000
Closed -$1.25M – 3729
2015
Q1 		$1.25M Buy
+20,000
New +$1.22M ﹤0.01% 2380

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's ANIP Position: Q2 2026 in Review

David Shaw reduced its ANI Pharmaceuticals (ANIP) stake by 18% in Q2 2026, selling an estimated $3.1M and leaving 174,732 shares worth $14.5M. The position accounts for 0.01% of the portfolio, ranked #1537.

David Shaw first reported a position in ANIP in Q2 2013 and has held it in 28 quarters since. The position peaked at $20M in Q4 2025. 305 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • David Shaw held 174,732 shares of ANI Pharmaceuticals worth $14.5M as of Q2 2026.
  • David Shaw sold 38,701 ANI Pharmaceuticals shares in Q2 2026, an estimated $3.1M.
  • ANI Pharmaceuticals made up 0.01% of David Shaw's portfolio in Q2 2026, its #1537 holding.
  • David Shaw first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 28 quarters since.
  • David Shaw's ANI Pharmaceuticals position peaked at $20M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.